133 related articles for article (PubMed ID: 24637698)
1. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.
Franceschi L; Cojutti P; Baraldo M; Pea F
Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698
[TBL] [Abstract][Full Text] [Related]
2. Stability of meropenem in normal saline solution after storage at room temperature.
Jaruratanasirikul S; Sriwiriyajan S
Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
[TBL] [Abstract][Full Text] [Related]
3. Stability of meropenem and doripenem solutions for administration by continuous infusion.
Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM
J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578
[No Abstract] [Full Text] [Related]
4. Stability of generic brands of meropenem reconstituted in isotonic saline.
Carlier M; Stove V; Verstraete AG; De Waele JJ
Minerva Anestesiol; 2015 Mar; 81(3):283-7. PubMed ID: 25220554
[TBL] [Abstract][Full Text] [Related]
5. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
Smith DL; Bauer SM; Nicolau DP
Am J Health Syst Pharm; 2004 Aug; 61(16):1682-5. PubMed ID: 15540479
[TBL] [Abstract][Full Text] [Related]
6. Stability of meropenem in intravenous solutions.
Patel PR; Cook SE
Am J Health Syst Pharm; 1997 Feb; 54(4):412-21. PubMed ID: 9043564
[TBL] [Abstract][Full Text] [Related]
7. Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
Mendez AS; Dalomo J; Steppe M; Schapoval EE
J Pharm Biomed Anal; 2006 Jun; 41(4):1363-6. PubMed ID: 16533586
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis.
Kuti JL; Nightingale CH; Knauft RF; Nicolau DP
Clin Ther; 2004 Apr; 26(4):493-501. PubMed ID: 15189746
[TBL] [Abstract][Full Text] [Related]
9. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
10. Thermal and alkaline stability of meropenem: degradation products and cytotoxicity.
Mendez A; Chagastelles P; Palma E; Nardi N; Schapoval E
Int J Pharm; 2008 Feb; 350(1-2):95-102. PubMed ID: 17904314
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W
Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the stability of meropenem in intravenous mixtures.
Takasu Y; Yoshida M; Tange M; Asahara K; Uchida T
Chem Pharm Bull (Tokyo); 2015; 63(4):248-54. PubMed ID: 25832020
[TBL] [Abstract][Full Text] [Related]
13. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic assay for meropenem in serum.
Elkhaïli H; Niedergang S; Pompei D; Linger L; Leveque D; Jehl F
J Chromatogr B Biomed Appl; 1996 Nov; 686(1):19-26. PubMed ID: 8953188
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of 2-hydropropyl-beta-cyclodextrin in the stabilization of frozen formulations.
Wong J; Kipp JE; Miller RL; Nair LM; Ray GJ
Eur J Pharm Sci; 2014 Oct; 62():281-92. PubMed ID: 24932711
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem).
Leelarasamee A; Rongrungruang Y; Trakulsomboon S; Pongpech P; Thanawattanawanich P; Jithavech P
J Med Assoc Thai; 2008 Jul; 91(7):980-8. PubMed ID: 18839835
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of stability-indicating HPLC method for simultaneous determination of meropenem and potassium clavulanate.
Zalewski P; Cielecka-Piontek J; Paczkowska M
Acta Pol Pharm; 2014; 71(2):255-60. PubMed ID: 25272645
[TBL] [Abstract][Full Text] [Related]
18. Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
Esteban-Cartelle B; Serrano DR; Pérez Menéndez-Conde C; Vicente-Oliveros N; Álvarez-Díaz A; Abete JF; Martín-Dávila P
Microbiol Spectr; 2024 Feb; 12(2):e0206323. PubMed ID: 38230930
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T
J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254
[TBL] [Abstract][Full Text] [Related]
20. The stability of a novel carbapenem antibiotic, meropenem (SM-7338), in a solid state formulation for injection.
Takeuchi Y; Takebayashi Y; Sunagawa M; Isobe Y; Hamazume Y; Uemura A; Noguchi T
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1998-2002. PubMed ID: 8293523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
